Dr. Bhadresh K. Patel, M.D.
Internal Medicine (Internal Medicine Physician)
- Medicare participating
At a glance
- Years since graduation
- 39
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 1,151
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Internal Medicine Physician primary
FL license ME0069230
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- HCA Florida Citrus Hospital Inverness, FL
- Tampa General Hospital Crystal River Crystal River, FL
Medical groups
- West Florida Medical Associates, PA (24 clinicians)
- Nature Coast Geriatric Services LLC (14 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,151
- Services billed
- 5,283
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Insertion of needle into vein for collection of blood sample | 1,165 | 707 |
| Annual depression screening, 5 to 15 minutes | 764 | 764 |
| Established patient office or other outpatient visit, 30-39 minutes | 584 | 271 |
| Established patient office or other outpatient visit, 20-29 minutes | 382 | 194 |
| Injection of drug or substance under skin or into muscle | 243 | 120 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 191 | 191 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 184 | 42 |
| Hemoglobin a1c level | 171 | 121 |
| Urinalysis, manual test | 157 | 115 |
| Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | 154 | 55 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 13 companies reported 42 payments worth $749 in total to this clinician.
| Amgen Inc. | $158 |
|---|---|
| GlaxoSmithKline, LLC. | $105 |
| AstraZeneca Pharmaceuticals LP | $102 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $78.76 |
| AbbVie Inc. | $64.96 |
| Novo Nordisk Inc | $57.87 |
| Abbott Laboratories | $47.91 |
| Pfizer Inc. | $35.25 |
| Food and Beverage | $749 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 3 industry-funded studies in 2025, from 2 companies. The companies reported $472,003 in research payments for these studies, mostly to the institutions running them.
- A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a Non-adjuvanted Influenza Vaccine in Adults ≥65 Years of Age
Seqirus USA Inc · Completed · NCT06087640 - A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ≥50 Years of Age
ModernaTX, Inc. · Completed · NCT06602024 - A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ≥12 Years of Age to Prevent COVID-19
ModernaTX, Inc. · Completed · NCT05815498
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.